slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 5,881-5,910
Pages 350
Rows per page 30
Slide type
5,881-5,910 of 10,471
09
The slide uses a circular process diagram to illustrate the feedback loop between data, AI, and wet lab validation.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
14
The slide highlights the efficacy of the company's de novo design model by comparing it against a known benchmark (trastuzumab).Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
15
Case study slide demonstrating model specificity and performance improvement over existing biological datasets.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
23
Case study slide showing correlation metrics (Pearson, Spearman, RMSE) and a histogram comparing predicted affinity to Trastuzumab.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
26
The slide uses a histogram to visualize the distribution of binding affinity (-log10(KD)) for designed variants compared to the wild-type Trastuzumab baseline.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Visualization1 hit
30
Includes a biological diagram of TLS and a Kaplan-Meier survival curve.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
32
The slide highlights key performance indicators of their antibody discovery platform and the disease areas they are targeting.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
33
The slide uses a two-column layout to contrast the partners (left) with the value derived from those partnerships (right).Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
38
The slide uses a bar chart to show relative expression across different nsAA incorporation counts, alongside a structural model of the antibody.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
43
The slide uses a mix of imagery and key metrics to establish credibility.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations 1 hit
11
The slide uses two semi-logarithmic line charts to compare drug concentration decay over time.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a comparative bar chart approach to justify the human half-life prediction based on NHP data.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
23
The slide uses two distinct chart types to demonstrate potency (dose-response curve) and diversity (scatter plot of IC50 vs Relative DcR3/DR3 Blocking).Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
11
Pharmacokinetic study results showing extended half-life for the drug candidate.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · Evidence & Proof1 hit
35
The slide combines financial runway with a clinical development timeline.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
11
The slide uses a comparison table to validate the market potential of the radiopharmaceutical space by highlighting a competitor's success.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
18
Waterfall plot displays individual patient responses; benchmarking table compares ORR against historical standards.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
19
The chart tracks patient follow-up in weeks, with markers indicating dose, dose reduction, and clinical response (Partial Response, Progressive Disease, Stable Disease).RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
24
Includes a visual case study with PET scan images showing tumor reduction.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
25
The chart shows tumor growth over 57 days across four treatment groups, with the combination therapy (green line) demonstrating the most effective tumor suppression.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
33
Comparison of 225Ac vs 177Lu efficacy at significantly different dose levels.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
34
Includes clinical imaging examples for two patients.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
35
The slide uses a longitudinal imaging sequence to demonstrate drug efficacy/retention.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
37
The slide lists 24 investor logos/names.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
06
The slide uses a bar chart to represent asset growth over time, with logos marking the founding years of subsidiaries.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations 1 hit
08
The slide uses a 'Challenge-Solution' framework paired with a stacked bar chart to visualize operational milestones.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations 1 hit
10
The slide uses a grid of testimonials and press clippings alongside a photo collage to build social proof.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations Loop · Why Now1 hit
14
Includes a stock price chart and key performance metrics from the listing day.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
Slide highlights both domestic marketing traction (Vietnam exhibition) and international operational milestones (NC factory, shipments, European retail expansion).VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a grid of big numbers to highlight scale and progress.VinFast | Investor Presentation Deck | 33 slides · VinFast
Pitch deck Investor relations Loop · Cost Of Inaction1 hit